Flores, Yonita M.
HRN: 04-50-27 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/11/2024
METRONIDAZOLE 500MG (TAB)
03/11/2024
03/17/2024
PO
1 Tab
TID
SP Primary LTCS
Waiting Final Action
Indication: Prophylaxis Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes